US Stock MarketDetailed Quotes

HROW Harrow

Watchlist
  • 40.020
  • -1.840-4.40%
Close Dec 3 16:00 ET
1.43BMarket Cap-42126P/E (TTM)

About Harrow Company

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

Company Profile

SymbolHROW
Company NameHarrow
Listing DateFeb 8, 2013
Founded2006
CEOMr. Mark L. Baum
MarketNASDAQ
Employees315
Fiscal Year Ends12-31
Address102 Woodmont Boulevard,Suite 610
CityNashville
ProvinceTennessee
CountryUnited States of America
Zip Code37205
Phone1-615-733-4730
Websitehttp://www.harrow.com

Company Executives

  • Name
  • Position
  • Salary
  • John Saharek
  • Chief Commercial Officer; President and Chief Executive Officer, ImprimisRx
  • 5.82M
  • Mark L. Baum
  • Chief Executive Officer and Chairman of the Board
  • 15.26M
  • Andrew R. Boll
  • Chief Accounting Officer, Chief Financial Officer and Corporate Secretary
  • 7.13M
  • Lauren P. Silvernail
  • Director
  • --
  • Dr. Adrienne L. Graves,PhD
  • Director
  • --
  • Perry J. Sternberg
  • Lead Independent Director
  • 202.50K
  • Dr. Martin A. Makary, M.D.
  • Independent Director
  • 205.00K
  • Teresa F. Sparks
  • Independent Director
  • 227.50K
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Cannabis & Hemp
Cannabis & Hemp
Intraday+1.83%